HMG 75IU

Biological research preparation · Janoshik verified · Lyophilized powder

$39.99

HMG shipping is unavailable in CO, CT, MN, NV, NY, NC, PA.

Out of stock

Payment options

Credit & debit cardsMajor card brands accepted
Zelle Cash App

Apple Pay & Google Pay on supported devices.

Sold by the vial. Quantity 1 = one vial. Vial size & quantity guide

PUBLISHED DOCUMENTATION

Review the report and its scope before ordering.

Published results describe the samples, sizes and batches identified in each report. A report for one size or batch does not establish results for other sizes or batches.

Verify report
Consult the original report for analytical methods, results and limitations.
Product-specific reports
Primary Current batch report

81.53 mcg · Batch PP2602-0222 · Tested size 75 IU · Janoshik #152448

Laboratory Research Use Only. Not for use in diagnostic procedures. This product is solely intended for controlled in vitro laboratory research as a chemical reference compound. Product information is provided for educational and documentation purposes. It should only be handled by qualified laboratory professionals and must not be misrepresented, misused, or mislabeled as a drug, food, cosmetic, or medical device. By purchasing from Panda Peptides, you acknowledge that you are acquiring a research chemical.

HMG 75IU is a urinary-derived glycoprotein preparation (CAS 9002-68-0) containing two heterodimeric glycoprotein components that share a common α-subunit. Standardized to 75 IU per vial. Supplied as lyophilized powder, third-party tested by Janoshik Analytical. Research compound — not for human use.

Compound Specifications

HMG (CAS 9002-68-0) is a preparation of urinary-derived glycoproteins consisting of two heterodimeric components. Both components share a common 92-amino-acid α-subunit (~14.5 kDa protein core) and differ by their unique β-subunits of 111 and 121 amino acids, respectively. The α-subunit contains two N-linked glycosylation sites (Asn-52, Asn-78), contributing to the characteristic heterogeneity observed in electrophoretic and chromatographic analyses. Research compound — not for human use.

Product Details

  • Compound: HMG (Urinary Glycoprotein Preparation)
  • CAS: 9002-68-0
  • Components: Two heterodimeric glycoproteins with shared α-subunit
  • α-Subunit: 92 amino acids, ~14.5 kDa (protein core), two N-glycosylation sites
  • β-Subunits: 111 aa (~15.5 kDa) and 121 aa (~16.7 kDa), each with 1–2 N-glycosylation sites
  • Native MW: ~30–38 kDa per heterodimer (glycosylation-dependent)
  • Potency: 75 IU (standardized bioassay)
  • Form: Lyophilized powder (white to off-white)
  • Solubility: Soluble in aqueous buffers
  • Testing: Third-party verified by Janoshik Analytical → View COA
  • Storage: 2–8°C desiccated, protect from light.
  • Testing: View COA (Verified by Janoshik Analytical) →

Research Studies

Structural Characterization

HMG preparations consist of non-covalently associated α/β heterodimers. The α-subunit is encoded by a single gene (chromosome 6q21.1-23) and is structurally conserved across both glycoprotein components. It features a cystine knot motif formed by three intramolecular disulfide bonds, a structural element common to the cystine knot growth factor superfamily. The distinct β-subunits each contribute additional disulfide bonds (six in the 111-aa subunit, six in the 121-aa subunit), yielding the characteristic tightly folded tertiary structure.

Physicochemical Properties

The isoelectric point of HMG glycoprotein components ranges from pH 3.5–5.5, reflecting extensive sialylation of the N-linked oligosaccharide chains. Charge heterogeneity arises primarily from variable terminal sialic acid residues. The preparations can be resolved by isoelectric focusing into multiple glycoforms, a property used in quality control characterization. The lyophilized form demonstrates excellent long-term stability when stored desiccated at 2–8°C.